Spark Biomedical, Inc Semi-Finalist in Texas A&M New Ventures Competition

Spark Biomedical, Inc Semi-Finalist in Texas A&M New Ventures Competition

Read MoreAwards

College Station, TX, May 3, 2019 — As Texas A&M New Ventures Competition 2019 #TNVC2019 approaches, May 15 – 17, the semi-finalist list has been announced. Spark Biomedical, Inc. is proud to be listed among the esteemed semi-finalists. Aimed at promoting the commercialization of emerging technology, the competition recognizes companies with high-growth potential and provides seed funding to help them effectively execute their ideas and advance product development.

The Texas A&M Engineering Experiment Station and the Texas A&M University System along with a growing number of sponsors are working to ensure today’s innovative ideas become a reality through the Texas A&M New Ventures Competition. The Competition is open to all Texas-based companies seeking to bring new or enhanced technology to the marketplace. Participant companies must be technology- or science-focused independent ventures in the pre-seed/seed, start-up or early growth stages.Spark Biomedical, Inc. is a Texas-based medical device company and developer of a wearable, over-the-ear, neurostimulation solution for opioid withdrawal and addiction relief. The Phoenix™ device delivers mild electrical stimulation to cranial nerve branches for the treatment of symptoms associated with opioid withdrawal. The company’s vision, to ignite a brighter future through neurostimulation, is fueled by its unique blend of scientific expertise, technical innovation, and deep medical device industry experience. For more information, visit or follow us on LinkedIn


Download the Updated Clinical Trial Whitepaper
Download Today

Wondering if ther's a better way to help patients overcome opioid withdrawal? Download the clinical trial whitepaper to learn more.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.